In thyroid and gastric cancer cells, overexpression of SIRT4 blocks the progression of the cancer cell cycle by inactivating ERK, p-ERK, cyclin D (ACT/GSK3ß/CyclinD1 pathway) and cyclin E [151,152,153,154]. Here, CCND1 is linked to cancer.